05.02.2013 Views

Bulletin 2011/35 - European Patent Office

Bulletin 2011/35 - European Patent Office

Bulletin 2011/35 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) II.1(1)<br />

A61K 31/501 → (51) C07D 491/10<br />

A61K 31/5025 → (51) A61P 21/00<br />

A61K 31/5025 → (51) C07D 487/04<br />

A61K 31/505 → (51) A61K 9/16<br />

(51) A61K 31/513 (11) 2 073 810 B1<br />

A61P 3/10 A61P <strong>35</strong>/00<br />

A61P 31/18 A61P 5/50<br />

(25) En (26) En<br />

(21) 07842260.7 (22) 11.09.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 01.07.2009<br />

(86) US 2007/078177 11.09.2007<br />

(87) WO 2008/033851 2008/12 20.03.2008<br />

(30) 13.09.2006 PCT/US2006/0<strong>35</strong>958<br />

13.03.2007 US 894628 P<br />

(54) • VERWENDUNG VON 2-6-(3-AMIN-PIPERI-<br />

DIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-<br />

DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL-4-<br />

FLUOR-BENZONITRIL ZUR BEHANDLUNG<br />

VON DIABETES, KREBS, AUTOIMMUNER-<br />

KRANKUNGEN UND HIV-INFEKTIONEN<br />

• USE OF 2-6-(3-AMINO-PIPERIDIN-1-YL)-<br />

3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-<br />

PYRIMIDIN-1-YLMETHYL-4-FLUORO-BEN-<br />

ZONITRILE FOR TREATING DIABETES,<br />

CANCER, AUTOIMMUNE DISORDERS AND<br />

HIV INFECTION<br />

• ADMINISTRATION DU 2-6-(3-AMINO-<br />

PIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-<br />

3,4-DIHYDRO-2H-PYRIMIDIN-1-YLME-<br />

THYL-4-FLUORO-BENZONITRILE POUR LE<br />

TRAITEMENT DU DIABÈTE, DU CANCER,<br />

DES TROUBLES AUTO-IMMUNITAIRES ET<br />

DE L'INFECTION PAR LE VIH<br />

(73) Takeda Pharmaceutical Company Limited, 1-<br />

1, Doshomachi 4-chome Chuo-ku, Osakashi,<br />

Osaka 541-0045, JP<br />

(72) CHRISTOPHER, Ronald J., Carlsbad, CA<br />

9<strong>2011</strong>, US<br />

OGAWA, Atsushi, Osaka 532-8686, JP<br />

COVINGTON, Paul, Wilmington, North Carolina<br />

28409, US<br />

(74) Duncan, Garreth Andrew, et al, D Young &<br />

Co LLP 120 Holborn, London EC1N 2DY, GB<br />

A61K 31/517 → (51) C07D 239/70<br />

A61K 31/519 → (51) C07D 487/04<br />

A61K 31/52 → (51) A61K 31/42<br />

A61K 31/538 → (51) C07D 265/36<br />

A61K 31/5415 → (51) C07D 265/36<br />

(51) A61K 31/55 (11) 2 117 553 B1<br />

A61P 11/00 A61P 27/16<br />

(25) En (26) En<br />

(21) 08729826.1 (22) 14.02.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 18.11.2009<br />

(86) US 2008/053918 14.02.2008<br />

(87) WO 2008/101052 2008/34 21.08.2008<br />

(30) 16.02.2007 US 675930<br />

(54) • ZUSAMMENSETZUNGEN ZUR BEHAND-<br />

LUNG, REDUKTION, VERMINDERUNG<br />

ODER VERHINDERUNG VON INFEKTIONEN<br />

DES OHRS ODER DER OBEREN ATEM-<br />

WEGE<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• COMPOSITIONS FOR TREATING, REDU-<br />

CING, AMELIORATING, OR PREVENTING<br />

INFECTIONS OF THE EAR OR UPPER<br />

RESPIRATORY TRACK<br />

• COMPOSITIONS POUR LE TRAITEMENT,<br />

LA RÉDUCTION, L'AMÉLIORATION, OU LA<br />

PRÉVENTION D'INFECTIONS DE<br />

L'OREILLE OU DE LA VOIE RESPIRATOIRE<br />

SUPÉRIEURE<br />

(73) Bausch & Lomb Incorporated, One Bausch &<br />

Lomb Place, Rochester, NY 14604-2701, US<br />

(72) VENKATESH, Srini, Pittsford, NY 14534, US<br />

JONASSE, Matthew, Scott, Webster, NY<br />

14580, US<br />

WANG, Hongna, Fairport, NY 14450, US<br />

(74) Glas, Holger, Maiwald <strong>Patent</strong>anwalts GmbH<br />

Elisenhof Elisenstrasse 3, 803<strong>35</strong> München,<br />

DE<br />

A61K 31/55 → (51) C07D 487/04<br />

(51) A61K 31/557 (11) 1 443 938 B1<br />

A61P 1/10<br />

(25) En (26) En<br />

(21) 02780083.8 (22) 14.11.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

(43) 11.08.2004<br />

(86) JP 2002/011862 14.11.2002<br />

(87) WO 2003/041716 2003/21 22.05.2003<br />

(30) 14.11.2001 US 331316 P<br />

(54) • DOSIERUNGSEINHEIT ENTHALTEND<br />

PROSTAGLANDIN-ANALOG ZUR<br />

BEHANDLUNG VON DARMVERSTOPFUNG<br />

• DOSAGE UNIT COMPRISING A PROSTA-<br />

GLANDIN ANALOG FOR TREATING CON-<br />

STIPATION<br />

• UNITE POSOLOGIQUE CONTENANT UN<br />

ANALOGUE DE PROSTAGLANDINE PER-<br />

METTANT DE TRAITER LA CONSTIPATION<br />

(73) Sucampo AG, Graben 5, 6300 Zug, CH<br />

(72) UENO, Ryuji, Montgomery, MD 20854, US<br />

PATCHEN, Myra, L., Fairfax, VA 22033-2732,<br />

US<br />

(74) Albrecht, Thomas, et al, Kraus & Weisert<br />

<strong>Patent</strong>- und Rechtsanwälte Thomas-Wimmer-Ring<br />

15, 80539 München, DE<br />

(60) 10010211.0 / 2 298 314<br />

(51) A61K 31/58 (11) 2 263 676 B1<br />

A61P 31/12<br />

(25) En (26) En<br />

(21) 10153974.0 (22) 18.02.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA RS<br />

(43) 22.12.2010<br />

(30) 16.06.2009 TW 098120040<br />

28.10.2009 TW 098136423<br />

(54) • Zusammensetzungen zur Hemmung oder<br />

Behandlung von Hepatitis-C-Viren<br />

• Compositions for inhibiting or treating<br />

Hepatitis C viruses<br />

• Compositions pour l'inhibition ou le traitement<br />

du virus de l'hépatite C<br />

(73) Industrial Technology Research Institute,<br />

195 Chung Hsing Road, Sec. 4, Chutung,<br />

Hsinchu 31040, TW<br />

(72) Lee, Lain-Tze, 300, Hsinchu City, TW<br />

Chang, Shau-Feng, 30069, Hsinchu City, TW<br />

Tsai, Hui-Ping, Hsinchu City, TW<br />

Kuo, Zong-Keng, 2<strong>35</strong>48, Zhonghe City, TW<br />

Chung, Chen-Fang, 30<strong>35</strong>3, Hsinchu County,<br />

TW<br />

(74) Fuchs, <strong>Patent</strong>anwälte Westhafenplatz 1,<br />

60327 Frankfurt am Main, DE<br />

406<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>35</strong>/<strong>2011</strong>) 31.08.<strong>2011</strong><br />

A61K 31/58 → (51) A61K 31/722<br />

A61K 31/593 → (51) A61K 31/722<br />

A61K 31/664 → (51) C12N 15/88<br />

(51) A61K 31/70 (11) 1 079 824 B1<br />

A61K 31/704 A61K 41/00<br />

(25) En (26) En<br />

(21) 99924348.8 (22) 19.05.1999<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 07.03.2001<br />

(86) US 1999/011041 19.05.1999<br />

(87) WO 1999/059578 1999/47 25.11.1999<br />

(30) 19.05.1998 US 85997 P<br />

03.09.1998 US 99066 P<br />

(54) • TRITERPENZUSAMMENSETZUNGEN UND<br />

DEREN VERWENDUNGSMETHODEN<br />

• TRITERPENE COMPOSITIONS AND<br />

METHODS FOR USE THEREOF<br />

• COMPOSITIONS DE TRITERPENE ET<br />

LEURS CHAMP D'APPLICATION<br />

(73) RESEARCH DEVELOPMENT FOUNDATION (a<br />

Nevada corporation), 402 North Division<br />

Street, Carson City Nevada 89703, US<br />

(72) ARNTZEN, Charles, J., Ithaca, NY 14850-<br />

1447, US<br />

BLAKE, Mary, Tucson, AZ 85718-1364, US<br />

GUTTERMAN, Jordan, U., Houston, TX<br />

77004, US<br />

HOFFMANN, Joseph, J., Tucson, AZ 85716,<br />

US<br />

BAILEY, David, T., Boulder, CO 80302, US<br />

JAYATILAKE, Gamini, S., Broomfield, CO<br />

80020, US<br />

(74) McQueen, Andrew Peter, et al, Stevens,<br />

Hewlett & Perkins 1 St. Augustine's Place,<br />

Bristol BS1 4UD, GB<br />

A61K 31/7036 → (51) A61K 31/42<br />

A61K 31/704 → (51) A61K 31/70<br />

A61K 31/7084 → (51) C12N 15/88<br />

A61K 31/7088 → (51) C12N 15/09<br />

A61K 31/7105 → (51) C07H 21/04<br />

A61K 31/711 → (51) C07H 21/04<br />

(51) A61K 31/722 (11) 2 117 564 B1<br />

A61K 31/58 A61K 31/4418<br />

A61K 31/593 A61K 45/06<br />

A61K 8/73 A61P 17/00<br />

A61P 17/06 A61Q 3/02<br />

(25) En (26) En<br />

(21) 08716765.6 (22) 07.02.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

RS<br />

(43) 18.11.2009<br />

(86) EP 2008/051477 07.02.2008<br />

(87) WO 2008/098869 2008/34 21.08.2008<br />

(30) 14.02.2007 EP 071023<strong>35</strong><br />

(54) • VERWENDUNG VON CHITOSANEN ZUM<br />

ERHÖHEN DER NAGELWACHSTUMSRATE<br />

• USE OF CHITOSANS TO INCREASE NAIL<br />

GROWTH RATE<br />

• UTILISATION DE CHITOSANE POUR AUG-<br />

MENTER LE TAUX DE CROISSANCE DES<br />

ONGLES<br />

(73) Polichem SA, 50, Val Fleuri, 1526 Luxembourg,<br />

LU<br />

(72) MR. FEDERICO, MAILLAND, I-20121 Milan,<br />

IT

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!